| Literature DB >> 26293821 |
Dounia Houamel1, Nicolas Ducrot1, Thibaud Lefebvre2, Raed Daher1, Boualem Moulouel1, Marie-Agnes Sari3, Philippe Letteron4, Said Lyoumi1, Sarah Millot1, Jerome Tourret5, Odile Bouvet5, Sophie Vaulont6, Alain Vandewalle4, Erick Denamur5, Hervé Puy2, Carole Beaumont1, Laurent Gouya2, Zoubida Karim7.
Abstract
The iron-regulatory peptide hepcidin exhibits antimicrobial activity. Having previously shown hepcidin expression in the kidney, we addressed its role in urinary tract infection (UTI), which remains largely unknown. Experimental UTI was induced in wild-type (WT) and hepcidin-knockout (Hepc-/-) mice using the uropathogenic Escherichia coli CFT073 strain. Compared with infected WT mice, infected Hepc-/- mice showed a dramatic increase in renal bacterial load. Moreover, bacterial invasion was significantly dampened by the pretreatment of WT mice with hepcidin. Infected Hepc-/- mice exhibited decreased iron accumulation in the renal medulla and significant attenuation of the renal inflammatory response. Notably, we demonstrated in vitro bacteriostatic activity of hepcidin against CFT073. Furthermore, CFT073 repressed renal hepcidin, both in vivo and in cultured renal cells, and reduced phosphorylation of SMAD kinase in vivo, suggesting a bacterial strategy to escape the antimicrobial activities of hepcidin. In conclusion, we provide new mechanisms by which hepcidin contributes to renal host defense and suggest that targeting hepcidin offers a strategy to prevent bacterial invasion.Entities:
Keywords: cell and transport physiology; cell signaling; kidney disease; pyelonephritis; renal epithelial cell; renal protection
Mesh:
Substances:
Year: 2015 PMID: 26293821 PMCID: PMC4769187 DOI: 10.1681/ASN.2014101035
Source DB: PubMed Journal: J Am Soc Nephrol ISSN: 1046-6673 Impact factor: 10.121